Literature DB >> 16999983

The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1.

Kevin Olivieri1, Robert M Scoggins, Yeou-cherng Bor, Aprille Matthews, David Mark, James R Taylor, David Chernauskas, Marie-Louise Hammarskjöld, David Rekosh, David Camerini.   

Abstract

Late stage AIDS associated CCR5 tropic HIV-1 clones (R5-AIDS HIV-1) exhibit greater cytopathic effects (CPE) than earlier isolates from the same patients. In this study, envelopes from a series of three biological clones derived from the same patient were evaluated as a cytopathic determinant of R5-AIDS HIV-1 for thymocytes. In a single round of replication in thymocytes, the AIDS associated clone mediated greater initiation of reverse transcription. This enhancement was not due to broadened coreceptor tropism, as all clones studied were exclusively R5 tropic. The full-length R5-AIDS env mediated greater infectivity than R5 pre-AIDS env when used to pseudotype a reporter virus. R5-AIDS env pseudotypes were more resistant to TAK-779 and showed more rapid infection kinetics but similar resistance to a CD4 blocking mAb. We conclude that the enhanced thymic replication and CPE shown by the R5-AIDS clone is due to enhanced efficiency of Env-mediated entry via CCR5.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16999983     DOI: 10.1016/j.virol.2006.08.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Genetic signatures of HIV-1 envelope-mediated bystander apoptosis.

Authors:  Anjali Joshi; Raphael T C Lee; Jonathan Mohl; Melina Sedano; Wei Xin Khong; Oon Tek Ng; Sebastian Maurer-Stroh; Himanshu Garg
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

2.  HIV ENV glycoprotein-mediated bystander apoptosis depends on expression of the CCR5 co-receptor at the cell surface and ENV fusogenic activity.

Authors:  Anjali Joshi; Alice M Nyakeriga; Revathi Ravi; Himanshu Garg
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

3.  A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.

Authors:  Samantha H Johnston; Michael A Lobritz; Sandra Nguyen; Kara Lassen; Shirley Delair; Filippo Posta; Yvonne J Bryson; Eric J Arts; Tom Chou; Benhur Lee
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

4.  Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants.

Authors:  Himanshu Garg; Anjali Joshi; Robert Blumenthal
Journal:  AIDS Res Hum Retroviruses       Date:  2009-08       Impact factor: 2.205

Review 5.  Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.

Authors:  Kelechi Chikere; Tom Chou; Paul R Gorry; Benhur Lee
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

6.  An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.

Authors:  Emily J Platt; James P Durnin; Ujwal Shinde; David Kabat
Journal:  J Mol Biol       Date:  2007-09-12       Impact factor: 5.469

Review 7.  Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis.

Authors:  H Garg; R Blumenthal
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

8.  Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands.

Authors:  Thomas J Ketas; Shawn E Kuhmann; Ashley Palmer; Juan Zurita; Weijing He; Sunil K Ahuja; Per Johan Klasse; John P Moore
Journal:  Virology       Date:  2007-04-10       Impact factor: 3.616

Review 9.  HIV-1 induced bystander apoptosis.

Authors:  Himanshu Garg; Jonathon Mohl; Anjali Joshi
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048

10.  Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

Authors:  Jasminka Sterjovski; Melissa J Churchill; Anne Ellett; Lachlan R Gray; Michael J Roche; Rebecca L Dunfee; Damian F J Purcell; Nitin Saksena; Bin Wang; Secondo Sonza; Steven L Wesselingh; Ingrid Karlsson; Eva-Maria Fenyo; Dana Gabuzda; Anthony L Cunningham; Paul R Gorry
Journal:  Retrovirology       Date:  2007-12-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.